{"id":1660,"date":"2022-10-21T00:35:26","date_gmt":"2022-10-20T21:35:26","guid":{"rendered":"https:\/\/www.sightsciences.com\/us\/?p=1660"},"modified":"2022-10-21T00:35:26","modified_gmt":"2022-10-20T21:35:26","slug":"sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022","status":"publish","type":"post","link":"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/","title":{"rendered":"Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022"},"content":{"rendered":"<div class=\"column large-12\">\n<div class=\"region region-content\">\n<div class=\"hidden\" data-drupal-messages-fallback=\"\"><\/div>\n<div id=\"block-nir-pid4158-content\" class=\"block--system-main-block block--system-main-block--7576 block--content--system-main-block block--content--system-main-block--7576 block--d3e5cab3-701e-469f-8150-a0c2ef34d4c7 block--d3e5cab3-701e-469f-8150-a0c2ef34d4c7--7576 block block-system block-system-main-block\">\n<article class=\"node node--nir-news--full node--type-nir-news node--view-mode-full node--promoted\" role=\"article\">\n<div class=\"field field--name-field-nir-news-title field--type-string field--label-hidden\">\n<\/div>\n<div class=\"file-link pdf-file-link\"><span class=\"file file--mime-application-pdf file--application-pdf\"><a href=\"\/node\/7576\/pdf\" target=\"_blank\" rel=\"noopener\">PDF Version<\/a><\/span><\/div>\n<div class=\"node__content\">\n<div class=\"box__wrap\"><\/div>\n<p><br class=\"\"><\/p>\n<p align=\"justify\">MENLO PARK, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tADuDVvd1E191OT0nt8Ta8OkpTgiNKX-eQ9O2FFqWoS_TH1ZFpOsD5MsvURAoocC426Ywnqv5rK5iHZAWFw3DL38Fe5CtUGfjEfGqfrA6dY=\" target=\"_blank\" rel=\"nofollow noopener\"><u>Sight Sciences, Inc<\/u><\/a>. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients\u2019 lives, today announced it will report financial results for the third quarter ended September 30, 2022, after the market close on Thursday, November 10, 2022. The company\u2019s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time.<\/p>\n<p><br class=\"\"><\/p>\n<p align=\"justify\">Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eP_n9T5YwX_CZ9azlxiFCGak79Fls48UeN3lF1nCgXxJnLGbEwOItYxMyqs0VlRxOr5DypuwROZUPjfEPKrPOT0j16JtROk3Vh2F83aeGcw=\" target=\"_blank\" rel=\"nofollow noopener\">www.sightsciences.com<\/a>, on the Investors page in the News &amp; Events section. The webcast will be available for replay for at least 90 days after the event.<\/p>\n<p><br class=\"\"><\/p>\n<p align=\"justify\"><strong>About Sight Sciences<\/strong><br \/>\nSight Sciences is an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients\u2019 lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world\u2019s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company\u2019s OMNI<sup>\u00ae<\/sup> Surgical System is a minimally invasive glaucoma surgery (MIGS) device indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma (POAG), the world\u2019s leading cause of irreversible blindness. The SION\u2122 Surgical Instrument is a bladeless, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The Company\u2019s TearCare<sup>\u00ae<\/sup> System is 510(k) cleared in the United States for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), enabling office-based clearance of gland obstructions by physicians to address the leading cause of dry eye disease.<\/p>\n<p><br class=\"\"><\/p>\n<p align=\"justify\">For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eP_n9T5YwX_CZ9azlxiFCGak79Fls48UeN3lF1nCgXwm_000Yg7D2feyOFpAIb3fEYFdECvULN8P4lcphkbEAkvYMNEz6HG2XRSxfV2jO6Q=\" target=\"_blank\" rel=\"nofollow noopener\">www.sightsciences.com<\/a>.<\/p>\n<p><br class=\"\"><\/p>\n<p align=\"justify\">OMNI<sup>\u00ae<\/sup> and TearCare<sup>\u00ae<\/sup> are registered trademarks of Sight Sciences.<br \/>\nSION\u2122 is a trademark of Sight Sciences.<br \/>\n\u00a9 2022 Sight Sciences. All rights reserved.<\/p>\n<p><br class=\"\"><br \/>\n<strong>Investor contact:<\/strong><br \/>\nPhilip Taylor<br \/>\nGilmartin Group<br \/>\n415.937.5406<br \/>\nInvestor.Relations@Sightsciences.com<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MWZiMjk4N2QtZGZiZi00YmJhLWE4ODctNTU3YzZhZTkwOTc0LTEyMjEzMjQ=\/tiny\/Sight-Sciences-Inc-.png\" alt=\"\" \/><\/p>\n<\/div>\n<\/article>\n<\/div>\n<div id=\"block-nir-pid4158-websitenoticeblock\" class=\"block--website-notice-block block--website-notice-block--7576 block--content--website-notice-block block--content--website-notice-block--7576 block--4d7a5f5e-26bd-48f8-9ae6-c5112267a7f5 block--4d7a5f5e-26bd-48f8-9ae6-c5112267a7f5--7576 block block-nir-website-notices block-website-notice-block\"><\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PDF Version MENLO PARK, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) &#8212; Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients\u2019 lives, today announced it will report financial results for the third quarter ended September 30, 2022, after the market close on Thursday, November [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-1660","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022 - United States<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022\" \/>\n<meta property=\"og:description\" content=\"PDF Version MENLO PARK, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) &#8212; Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients\u2019 lives, today announced it will report financial results for the third quarter ended September 30, 2022, after the market close on Thursday, November [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-20T21:35:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml.globenewswire.com\/media\/MWZiMjk4N2QtZGZiZi00YmJhLWE4ODctNTU3YzZhZTkwOTc0LTEyMjEzMjQ=\/tiny\/Sight-Sciences-Inc-.png\" \/>\n<meta name=\"author\" content=\"admin-dev\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin-dev\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\\\/\"},\"author\":{\"name\":\"admin-dev\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/#\\\/schema\\\/person\\\/88f84507b2364aa1168168756f61f091\"},\"headline\":\"Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022\",\"datePublished\":\"2022-10-20T21:35:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\\\/\"},\"wordCount\":336,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ml.globenewswire.com\\\/media\\\/MWZiMjk4N2QtZGZiZi00YmJhLWE4ODctNTU3YzZhZTkwOTc0LTEyMjEzMjQ=\\\/tiny\\\/Sight-Sciences-Inc-.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\\\/\",\"url\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\\\/\",\"name\":\"Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022 - United States\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ml.globenewswire.com\\\/media\\\/MWZiMjk4N2QtZGZiZi00YmJhLWE4ODctNTU3YzZhZTkwOTc0LTEyMjEzMjQ=\\\/tiny\\\/Sight-Sciences-Inc-.png\",\"datePublished\":\"2022-10-20T21:35:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/#\\\/schema\\\/person\\\/88f84507b2364aa1168168756f61f091\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ml.globenewswire.com\\\/media\\\/MWZiMjk4N2QtZGZiZi00YmJhLWE4ODctNTU3YzZhZTkwOTc0LTEyMjEzMjQ=\\\/tiny\\\/Sight-Sciences-Inc-.png\",\"contentUrl\":\"https:\\\/\\\/ml.globenewswire.com\\\/media\\\/MWZiMjk4N2QtZGZiZi00YmJhLWE4ODctNTU3YzZhZTkwOTc0LTEyMjEzMjQ=\\\/tiny\\\/Sight-Sciences-Inc-.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/#\\\/schema\\\/person\\\/88f84507b2364aa1168168756f61f091\",\"name\":\"admin-dev\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g\",\"caption\":\"admin-dev\"},\"url\":\"https:\\\/\\\/www.sightsciences.com\\\/us\\\/author\\\/admin-dev\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022 - United States","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/","og_locale":"en_US","og_type":"article","og_title":"Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022","og_description":"PDF Version MENLO PARK, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) &#8212; Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients\u2019 lives, today announced it will report financial results for the third quarter ended September 30, 2022, after the market close on Thursday, November [&hellip;]","og_url":"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/","og_site_name":"United States","article_published_time":"2022-10-20T21:35:26+00:00","og_image":[{"url":"https:\/\/ml.globenewswire.com\/media\/MWZiMjk4N2QtZGZiZi00YmJhLWE4ODctNTU3YzZhZTkwOTc0LTEyMjEzMjQ=\/tiny\/Sight-Sciences-Inc-.png","type":"","width":"","height":""}],"author":"admin-dev","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin-dev","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/#article","isPartOf":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/"},"author":{"name":"admin-dev","@id":"https:\/\/www.sightsciences.com\/us\/#\/schema\/person\/88f84507b2364aa1168168756f61f091"},"headline":"Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022","datePublished":"2022-10-20T21:35:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/"},"wordCount":336,"commentCount":0,"image":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/ml.globenewswire.com\/media\/MWZiMjk4N2QtZGZiZi00YmJhLWE4ODctNTU3YzZhZTkwOTc0LTEyMjEzMjQ=\/tiny\/Sight-Sciences-Inc-.png","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/","url":"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/","name":"Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022 - United States","isPartOf":{"@id":"https:\/\/www.sightsciences.com\/us\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/#primaryimage"},"image":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/ml.globenewswire.com\/media\/MWZiMjk4N2QtZGZiZi00YmJhLWE4ODctNTU3YzZhZTkwOTc0LTEyMjEzMjQ=\/tiny\/Sight-Sciences-Inc-.png","datePublished":"2022-10-20T21:35:26+00:00","author":{"@id":"https:\/\/www.sightsciences.com\/us\/#\/schema\/person\/88f84507b2364aa1168168756f61f091"},"breadcrumb":{"@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/#primaryimage","url":"https:\/\/ml.globenewswire.com\/media\/MWZiMjk4N2QtZGZiZi00YmJhLWE4ODctNTU3YzZhZTkwOTc0LTEyMjEzMjQ=\/tiny\/Sight-Sciences-Inc-.png","contentUrl":"https:\/\/ml.globenewswire.com\/media\/MWZiMjk4N2QtZGZiZi00YmJhLWE4ODctNTU3YzZhZTkwOTc0LTEyMjEzMjQ=\/tiny\/Sight-Sciences-Inc-.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.sightsciences.com\/us\/sight-sciences-to-report-third-quarter-2022-financial-results-on-november-10-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sightsciences.com\/us\/"},{"@type":"ListItem","position":2,"name":"Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022"}]},{"@type":"WebSite","@id":"https:\/\/www.sightsciences.com\/us\/#website","url":"https:\/\/www.sightsciences.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sightsciences.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.sightsciences.com\/us\/#\/schema\/person\/88f84507b2364aa1168168756f61f091","name":"admin-dev","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g","caption":"admin-dev"},"url":"https:\/\/www.sightsciences.com\/us\/author\/admin-dev\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/posts\/1660","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/comments?post=1660"}],"version-history":[{"count":0,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/posts\/1660\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/media?parent=1660"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/categories?post=1660"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sightsciences.com\/us\/wp-json\/wp\/v2\/tags?post=1660"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}